Bayesian Capital Management’s Ambev ABEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-123,600
Closed -$310K 662
2022
Q2
$310K Buy
+123,600
New +$352K 0.06% 471
2022
Q1
Sell
-85,700
Closed -$240K 755
2021
Q4
$240K Buy
+85,700
New +$246K 0.08% 290
2020
Q1
Sell
-19,900
Closed -$93K 754
2019
Q4
$93K Buy
+19,900
New +$88.3K 0.02% 566

Other funds holding ABEV

Bayesian Capital Management's ABEV Position: Q3 2022 in Review

Bayesian Capital Management sold out of Ambev (ABEV) in Q3 2022, closing a stake of 123,600 shares — an estimated $310K sold.

Bayesian Capital Management first reported a position in ABEV in Q4 2019 and held it in 3 quarters. The position peaked at $310K in Q2 2022. 295 funds tracked by Wall St. Rank hold ABEV as of Q3 2022.

  • Bayesian Capital Management reported no remaining Ambev position as of Q3 2022 after selling out during the quarter.
  • Bayesian Capital Management sold 123,600 Ambev shares in Q3 2022, an estimated $310K.
  • Bayesian Capital Management first reported a position in Ambev in Q4 2019 and held it in 3 quarters.
  • Bayesian Capital Management's Ambev position peaked at $310K in Q2 2022.
  • 295 funds tracked by Wall St. Rank held Ambev as of Q3 2022.

Based on Bayesian Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.